IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

Summary

This prospective, multicenter, single-arm, open-label phase II clinical study aimed to investigate the efficacy and safety of intensity-modulated radiotherapy combined with lobaplatin-based concurrent chemotherapy in the treatment of elderly patients with nasopharyngeal carcinoma

Timeline

Start

2024-11-13

Primary completion

2026-12-31

Completion

2027-12-31

Drugs

Indications